Status:
RECRUITING
IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients
Lead Sponsor:
University of Cologne
Collaborating Sponsors:
Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH
University of Regensburg
Conditions:
Cancer
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
IMPLEMENT aims to develop, test and establish a sustainable access structure for quality-assured oncological exercise therapy (qOET) in Germany as a model within the funding period of three years. Thi...
Detailed Description
IMPLEMENT is an exploratory, open-label, non-randomized, mixed-methods study. No additional treatments or therapies that can influence the course of the disease are provided to the participating patie...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with cancer
- Healthcare providers (e.g. Medical Doctors, physiotherapists, nurses, psychologists) involved in the treatment and/or counseling of cancer patients, including aftercare.
- Exclusion Criteria (Cancer Patients):
- Psychological and/or physical limitations that do not allow participation in quality-assured sports and exercise therapy (e.g. unstable cardiac arrhythmias)
Exclusion
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06496711
Start Date
September 1 2023
End Date
February 28 2026
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, Germany, 50937